Sofinnova Investments’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
2021
Q2
$4.86M Sell
2021
Q1
$7.43M Buy
2020
Q4
$10.3M Buy
2020
Q3
$3.52M Buy